Asthma in the era of COVID-19

被引:10
作者
Assaf, Sara [1 ]
Stenberg, Henning [2 ]
Jesenak, Milos [3 ,4 ]
Tarasevych, Svitlana P. [5 ]
Hanania, Nicola A. [6 ]
Diamant, Zuzana [7 ,8 ,9 ,10 ,11 ]
机构
[1] Univ New Mexico, Sect Pulm & Crit Care Med, Albuquerque, NM 87131 USA
[2] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden
[3] Comenius Univ, Univ Teaching Hosp, Jessenius Fac Med Martin, Dept Pulmonol & Phthisiol, Martin, Slovakia
[4] Comenius Univ, Univ Teaching Hosp Martin, Dept Paediat, Dept Clin Immunol & Allergol,Jessenius Fac Med Mar, Martin, Slovakia
[5] Zaans Med Ctr, Dept Resp Med, Zaandam, Netherlands
[6] Baylor Coll Med, Sect Pulm & Crit Care Med, Houston, TX USA
[7] Katholieke Univ Leuven, Dept Microbiol & Immunol, Catholic Univ Leuven, Louvain, Belgium
[8] Lund Univ, Skane Univ Hosp, Dept Resp Med & Allergol, Inst Clin Sci, Lund, Sweden
[9] Charles Univ Prague, Fac Med 1, Dept Resp Med, Prague, Czech Republic
[10] Thomayer Hosp, Prague, Czech Republic
[11] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
关键词
Asthma; COVID-19; Long COVID; Phenotypes; Biologicals; BRONCHIAL EPITHELIAL-CELLS; RISK; RHINOVIRUS; EXPRESSION; SARS-COV-2; HOSPITALIZATION; EXACERBATIONS; INFECTIONS; RECEPTOR;
D O I
10.1016/j.rmed.2023.107373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since its global invasion in 2019, COVID-19 has affected several aspects of patients' lives and posed a significant impact on the health care system. Several patient populations were identified to be at high risk of contracting SARS-CoV-2 infection and/or developing severe COVID-19-related sequelae. Conversely, anyone who has contracted SARS-CoV-2 is at risk to experience symptoms and signs consistent with post-COVID manifestations. Patients with asthma were initially thought to be at increased risk and severity for SARS-CoV-2 infection. However, accumulating evidence demonstrates that asthma endotypes/phenotypes and comorbidities influence the risk stratification in this population. Furthermore, initial concerns about the potentially increased risk of poor outcomes with asthma treatments such as inhaled corticosteroids and biologics have not been substantiated. In this review, we provide an update on COVID-19 and asthma, including risk of susceptibility, clinical manifestations and course in this population as well as discuss recommendations for management.
引用
收藏
页数:6
相关论文
共 86 条
[1]   The incidence and Severity of COVID-19 in the Liverpool Severe Asthma Population Undergoing Biologic Therapy [J].
Abdullah, Yahya .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
[2]   COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence [J].
Adir, Yochai ;
Humbert, Marc ;
Saliba, Walid .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (02) :361-+
[3]   Comparative Efficacy and Safety of Tezepelumab and Other Biologics in Patients with Inadequately Controlled Asthma According to Thresholds of Type 2 Inflammatory Biomarkers: A Systematic Review and Network Meta-Analysis [J].
Ando, Koichi ;
Fukuda, Yosuke ;
Tanaka, Akihiko ;
Sagara, Hironori .
CELLS, 2022, 11 (05)
[4]   Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study [J].
Aveyard, Paul ;
Gao, Min ;
Lindson, Nicola ;
Hartmann-Boyce, Jamie ;
Watkinson, Peter ;
Young, Duncan ;
Coupland, Carol A. C. ;
San Tan, Pui ;
Clift, Ashley K. ;
Harrison, David ;
Gould, Doug W. ;
Pavord, Ian ;
Hippisley-Cox, Julia .
LANCET RESPIRATORY MEDICINE, 2021, 9 (08) :909-923
[5]   Unraveling the Relationship of Asthma and COVID-19 [J].
Bakakos, Agamemnon ;
Bakakos, Petros ;
Rovina, Nikoletta .
JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12)
[6]   Genetics and epidemiology: asthma and infection [J].
Bartlett, Nathan W. ;
McLean, Gary R. ;
Chang, Yoon-Seok ;
Johnston, Sebastian L. .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 9 (05) :395-400
[7]   Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study [J].
Bergman, Jonathan ;
Ballin, Marcel ;
Nordstrom, Anna ;
Nordstrom, Peter .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2021, 36 (03) :287-298
[8]   Expression of intercellular adhesion molecule-1 (ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection? [J].
Bianco, A ;
Whiteman, SC ;
Sethi, SK ;
Allen, JT ;
Knight, RA ;
Spiteri, MA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) :339-345
[9]   Asthma Phenotypes and COVID-19 Risk A Population-based Observational Study [J].
Bloom, Chloe, I ;
Cullinan, Paul ;
Wedzicha, Jadwiga A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (01) :36-+
[10]   Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK [J].
Bloom, Chloe, I ;
Drake, Thomas M. ;
Docherty, Annemarie B. ;
Lipworth, Brian J. ;
Johnston, Sebastian L. ;
Nguyen-Van-Tam, Jonathan S. ;
Carson, Gail ;
Dunning, Jake ;
Harrison, Ewen M. ;
Baillie, J. Kenneth ;
Semple, Malcolm G. ;
Cullinan, Paul ;
Openshaw, Peter J. M. .
LANCET RESPIRATORY MEDICINE, 2021, 9 (07) :699-711